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Background: The minimal clinically important difference (MCID) that allows the interpretation of small
but meaningful changes after intervention has not been reported for the Liverpool Elbow Score (LES).
This study aimed to determine the MCID for the LES in patients undergoing total elbow replacement.
Methods: This observational study is based on preoperative and 1-year postoperative clinical outcome
of total elbow replacement (Discovery Elbow System) in 71 patients using the LES. A 4-point Likert-like
transition scale was used to evaluate patient satisfaction after total elbow replacement. A combination
of distribution-based methods (standard deviation [SD] of change in the LES, standard error of mean,
smallest detectable change [SDC]) and anchor-basedmethods (receiver operating curve, difference of mean
of change in LES) was used to determine range of MCID values.
Results: The mean change in the LES value was 2.4 (SD, 2.1). The estimated SDC value with upper limit
of 90% conﬁdence interval was 1.5. The mean change in LES of “satisﬁed” and “somewhat satisﬁed” patient
groups was 2.4 (SD, 2.1) and 1.1 (SD, 1.4), respectively, and the difference between both means (MCID
based on difference of mean in 2 subgroups) was 1.3. According to receiver operating curve analysis, the
value of MCID was 1.6.
Conclusion: The MCID value for the LES was estimated to range between 0.7 and 1.8. The estimated SDC
value was 1.5. We propose that the “true” MCID value of the LES would be between 1.6 and 1.8 to ensure
that the value is higher than the measurement error of the LES.
© 2017 The Authors. Published by Elsevier Inc. on behalf of American Shoulder and Elbow Surgeons.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
The Liverpool Elbow Score (LES) is a region-speciﬁc outcome score
that is completed by both the clinician and the patient. Validation
study by the developers of the score demonstrated that the LES is
valid, reliable, and responsive to change in clinical condition of the
patient in different elbow conditions.30 The LES has demonstrated
satisfactory responsiveness after total elbow replacement
arthroplasty.39 The LES has found support from other research groups
and has been used by independent groups other than the devel-
opers of the score. The LES has been used in assessment of functional
outcome after total elbow arthroplasty (TEA) in arthritis,1,3 func-
tional outcome after arthroscopic arthrolysis and hyaluronan gel in
post-traumatic elbow stiffness,25 difference in functional outcome
in a randomized controlled trial comparing platelet-rich plasma and
autologous whole blood in chronic tennis elbow,34 functional
outcome after internal ﬁxation of severe olecranon fracture,23 and
functional outcome after internal ﬁxation of intra-articular distal
humerus fracture.26
Establishing the minimal clinically important difference (MCID)
for clinical outcomes scores is an important component of out-
comes research to understand treatment effectiveness, particularly
from the patient’s perspective. The MCID is deﬁned as the small-
est change in the value of an outcome instrument that patients
perceive as important, beneﬁcial, or harmful.20 In other words, MCID
value differentiates patients who improve from those who do not
improve after a therapeutic intervention.18 The concept of MCID
assists in differentiating statistical signiﬁcance from clinical signif-
icance. A statistical test might reveal a signiﬁcant difference between
preoperative and postoperative scores of an outcome instrument;
however, if the difference is lower than the MCID value of the
outcome instrument, this statistically signiﬁcant difference is not
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deemed to be clinically signiﬁcant. The MCID value is also helpful
in evaluating cost-effectiveness, estimating appropriate sample size
for randomized controlled trials, and evaluating power of a
nonrandomized study.20
To our knowledge, the MCID value has not been determined for
the LES. Hence, this study aimed to critically evaluate the MCID of
the LES in a large cohort of patients who underwent TEA for various
underlying pathologic processes.
Methods
A prospective database of patients who had undergone TEA using
the Discovery Elbow System (Biomet Inc, Warsaw IN, USA) was re-
viewed to identify patients with completed preoperative LES and
1-year postoperative LES and satisfaction questionnaire. Identi-
ﬁed patients had undergone TEA for degenerative arthritis
(osteoarthritis, post-traumatic arthritis), inﬂammatory arthritis (rheu-
matoid arthritis, hemophiliac arthropathy, and psoriatic arthritis),
comminuted distal humerus fracture, and loosening of previous
elbow prostheses using the Discovery prosthesis between April 2003
and March 2013. Patient demographics are presented in the Results
section. All identiﬁed cases (N = 71) were operated on and fol-
lowed up in a single upper limb center.
Outcome assessment
Clinical and functional outcome after TEA was assessed using the
LES. Before the operation and at 1-year follow-up, patients ﬁrst com-
pleted the patient-answered questionnaire of the LES (PAQ-LES),
followed by completion of the clinical assessment part of the score
(CAS-LES) by independent research fellows. PAQ-LES includes 9 ques-
tions representing domains of pain (1 question), functional ability
to do activities of daily living (7 questions), and functional ability
to participate in sporting and recreational activities (1 question).
These questions are answered on a 5-point adjectival scale from 0
(maximum disability) to 4 (no functional disability). The CAS-LES
includes assessment of range of motion (4 items), muscle strength
(1 item), and ulnar nerve function (1 item). The points from PAQ-
LES and CAS-LES are then entered individually in a mathematical
formula to determine the total LES. In this scoring system, 0 and
10 points indicate the worst and best outcome, respectively.30,31
As there is no “gold standard” external criterion to assess change
and improvements in the clinical condition of the patient, a 4-point
Likert-like transition scale was used to evaluate patient satisfac-
tion after TEA. The options on this scale were very satisﬁed, satisﬁed,
somewhat satisﬁed, and unsatisﬁed. Patients answered this ques-
tion at postoperative follow-ups.
Estimation of MCID
There is no gold standard method to measure MCID, which can
be estimated using either anchor-based or distribution-based
methods. It has been recommended that studies use both anchor-
based and distribution-based methods to give range of values for
MCID and ﬁnally triangulate to converge on possible MCID value.7,42
It is also suggested that anchor-based methods be given greater
weight than distribution-based methods for converging on a single
value or to narrow the range of possible MCID values. Distribution-
based methods are solely used only when suitable external anchors
have not been used or are not available for use.28
This study determined the MCID using both anchor-based and
distribution-basedmethods. Patient satisfaction was used as a global
transition external anchor. This is in accordance with a similar ap-
proach by previous studies to estimate clinically meaningful
change.6,32 Adjusting for the change in unsatisﬁed patients, the MCID
can be calculated as the mean change score for satisﬁed patients
minus themean change score for somewhat satisﬁed patients.6,14,32,37
Receiver operating curve (ROC) analysis is then used to evaluate the
point that is closest to the upper left-hand corner of the curve rep-
resenting MCID.37,40 A diagonal is drawn from the upper left corner
of the ROC to the lower right corner. The point at which this diag-
onal intersects the curve is considered to be the point closest to the
upper left corner, and hence the value of change in the LES at this
site of intersection represents the MCID.37 For ROC analysis, pa-
tients who were unsatisﬁed and somewhat satisﬁed were grouped
into the “not improved” group, and those who were satisﬁed and
very satisﬁed were grouped into the “improved” group. The entire
cohort was included in the ROC analysis rather than just the values
adjacent to the point of dichotomy, as this has been shown to in-
crease precision of MCID estimation.36 Sensitivity is the proportion
of patients who are deﬁnitely satisﬁed and whose change in LES
is above the threshold MCID value. Speciﬁcity is the proportion of
patients who are not deﬁnitely satisﬁed and whose change in LES
is below the threshold MCID value.
For the distribution-based approach, we ﬁrst estimated the stan-
dard error of mean (SEM) and smallest detectable change (SDC). It
has been reported that estimates based on measurement preci-
sion of outcomemeasurement (SEM) are better than estimates based
on sample variation (effect size) or those based on statistical sig-
niﬁcance (paired t-test).9 SEM is an indicator of random error during
single use of an outcome instrument and is believed generally to
be stable across different populations and different studies.9,10 SDC
or minimum detectable change (MDC) refers to the smallest change
in the value of an outcome instrument that is greater than random
measurement error associated with use of the instrument.10 Both
SEM and SDC are determined in a stable subgroup of patients in the
study cohort. These patients either have perceived no change in clin-
ical condition after an intervention or have experienced negligible
or minimal change in their clinical condition.
Repeated application of an outcome instrument in the same
patient should give a similar value if the condition has remained
stable with no change. However, this is infrequently seen, and more
often repeated application gives rise to slight changes in the value
of the outcome instrument. This minimum change in value is likely
to be due to themeasurement error of the outcome instrument. SDC
or MDC represents the threshold value beyond which any in-
crease in the score of the outcome instrument is likely to indicate
“true” change in clinical condition instead of error due to repeat-
ed administration of the outcome tool. A change in the value of an
outcome instrument lower than the value of SDC might not indi-
cate true change in the clinical condition, as this is likely to be due
to the measurement error of the outcome instrument.
In this study, SEM was calculated as SEM = [standard deviation
(SD) of baseline preoperative LES] × [square root of 1 – α], wherein
α represents the reliability coeﬃcient of the test-retest value of the
outcome instrument in a stable group of patients5,10,17,19; α can be
represented as either Cronbach α or the intraclass correlation co-
eﬃcient. Commonly, 90% conﬁdence limit is chosen for MDC and
is calculated as MDC90 = (1.65) × (square root of 2) × (SEM).5,10,17,19
Cronbach α based on standardized items was used to measure the
reliability coeﬃcient of test-retest in a stable group of patients.19
Based on patients’ response to the 4-point Likert-like satisfaction
scale, those patients who felt somewhat satisﬁed after the TEA were
considered to be stable patients, as they probably did not have sig-
niﬁcant change in their clinical condition. Various threshold values
have been reported for the estimation of clinicallymeaningful change
based on SEM including 1 SEM,41 1.96 SEM, and 2.77 SEM.22 Norman
et al24 observed that a value of half the SD of the change in score
of the outcome instrument was equal to MCID in a variety of studies,
although it is believed that this is a conservative estimate of MCID.
SPSS version 18 (SPSS Inc., Chicago, IL, USA) was used to do the sta-
tistical analysis.
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Results
Study participants
The study included 71 patients who had the required preoper-
ative and postoperative data on LES and patient satisfaction (there
were nomissing data). Themean age of patients was 64 years (range,
22-93 years); 49 cases were female (69%), and 22 cases were male
(31%). There were 52 (73%) and 19 (27%) primary and revision TEA
cases, respectively; 45 cases (63%) presented with unilateral elbow
and 26 cases (37%) with bilateral elbow involvement. Underlying
disease was rheumatoid arthritis in 22 cases (31%), loosening of
elbow prosthesis in 19 cases (27%), post-traumatic arthritis in 11
cases (16%), primary osteoarthritis in 11 cases (16%), fracture of distal
humerus in 5 cases (7%), hemophiliac arthropathy in 2 cases (3%),
and arthritis due to synovial chondromatosis in 1 case (1%).
LES and patient satisfaction
The mean preoperative LES improved from 3.7 (SD, 1.8; range,
0.2-8.3) to 6.1 (SD, 1.71; range, 2.5-9.2). After TEA, 40 patients (56%)
were very satisﬁed, 18 patients (25%) satisﬁed, 10 patients (14%)
somewhat satisﬁed, and 3 patients (4%) unsatisﬁed.
Distribution-based approach
MCID
Based on SD of change in LES, the mean change in the value of
the LES was 2.4 (range, −1.7 to 8.7). The value of SD for change in
LES was 2.13. Using the criterion of ½ × SD, the estimated MCID was
1.1.
SDC and SEM
Ten patients chose the somewhat satisﬁed response at 1-year
follow-up. These patients were considered to have a stable clini-
cal condition as they did not have signiﬁcant satisfaction. In these
patients, the mean preoperative LES was 3.8 (SD, 2.1; range, 0.2-
6.8), and the mean postoperative LES was 4.9 (SD, 1.6; range, 2.7-
7.0). Cronbach α based on standardized items was estimated as 0.87.
The SD of the baseline preoperative LES of the entire cohort of 71
patients was 1.8. The SEM was estimated to be 0.66, and using cri-
teria of 1 SEM, 1.96 SEM, and 2.77 SEM resulted in the values of 0.7,
1.3, and 1.8, respectively. Based on themathematical formula already
described in the Methods section, the SDC with upper limit of 90%
conﬁdence interval was estimated as 1.5.
Anchor-based approach
MCID based on the difference of mean of change in LES
The mean change in LES of the satisﬁed group was 2.4 (SD, 2.1;
range, −1.5 to 6.2), whereas the mean change in LES of the some-
what satisﬁed group was 1.1 (SD, 1.4; range, −0.7 to 3.5). The
difference between both the means (MCID based on difference of
mean in 2 subgroups) was 1.3.
MCID based on ROC analysis
ROC analysis revealed the value of change of LES closest to the
upper left-hand corner of the graph (MCID) as 1.6 (sensitivity value
of 0.69 and speciﬁcity value of 0.69) (Fig. 1). The area under the curve
was 0.74 (P = .007; 95% conﬁdence interval, 0.61-0.88).
Triangulation approach: combined distribution- and anchor-based
approaches
Thus, using various methods, it was estimated that the true value
of MCID for the LES ranged fromminimum value of 0.7 to maximum
value of 1.8. The SDC value was estimated to be 1.5 in this study. It
is proposed that the true MCID value of the LES would be between
1.6 and 1.8 to ensure that the value is higher than the measure-
ment error of the LES.
Discussion
This study has estimated the range of possible values of MCID
using a combination of both anchor-based and distribution-based
methods. Some of the values were lower than the SDC values,
whereas some were higher than the SDC value of 1.5. Most studies
have used ROC analysis to estimateMCID, and in our study, theMCID
using ROC analysis was 1.6. We propose using the value of 1.6 for
calculating sample size for research trials as it is the value just higher
than the SDC value.
Patient satisfaction has been previously used as a global tran-
sition external criterion to estimate clinically meaningful change.6,32
It is recommended that correlation of change in value of the outcome
score with the external anchormust be at least 0.30 for it to be useful
for evaluation of MCID.27 A previously published study39 has shown
positive correlation between change in value of LES and patient sat-
isfaction (correlation coeﬃcient of 0.35). This justiﬁes our choice
of using patient satisfaction as an external anchor.
Some authors have used the 90% upper conﬁdence limit to es-
timate the SDC, calculated as the product of SEM with square root
value of 2 and 1.645.5,17 These authors have recommended using 90%
upper conﬁdence limit of the SDC instead of the 95% upper conﬁ-
dence limit because of its higher precision.5 By contrast, some authors
have used the 95% upper conﬁdence limit to estimate SDC, calcu-
lated as the product of SEMwith square root values of 2 and 1.96.16,38
SEM in the stable group of patients has been determined by the
Figure 1 Estimation of minimal clinically important difference using receiver op-
erating curve (ROC) analysis. A diagonal is drawn from the upper left corner to the
lower right corner. The point at which this diagonal intersects the curve repre-
sents the point closest to the upper left corner, and hence this represents the minimal
clinically important difference value of 1.6. The vertical and horizontal reference lines
are drawn to x-axis and y-axis, respectively. The vertical dotted reference line to x-axis
is through a point traversing 1 − speciﬁcity of 0.308. The horizontal dotted reference
line to y-axis is through a point traversing sensitivity of 0.690.
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formula SD divided by square root of 2, wherein SD was the change
in value of the outcome instrument in a stable group of patients.
MDC was determined by obtaining the product of SEM with square
root values of 2 and 1.65. MDC calculated by this method repre-
sented the upper 90% conﬁdence interval of the MDC. Calculating
MDC using this technique tended to overestimate the value of SDC.8
There is still no consensus regarding whether to use 90% or 95%
upper conﬁdence limit for calculating SDC.
The results of this study concur with the ﬁndings of de Boer
et al,13 who used patient satisfaction after elbow surgery as an ex-
ternal anchor. In that study, a larger difference in the LES value was
associated with higher satisfaction; a smaller difference was ob-
served in patients with lower satisfaction. This study used a 4-point
Likert-like scale, whereas de Boer et al13 used a 10-cm visual analog
scale (VAS) to assess patient satisfaction, converted into ordinal data
by arbitrarily categorizing patients scoring 0-2.5 points as dissat-
isﬁed, 2.5-5 points as somewhat satisﬁed, 5-7.5 points as moderately
satisﬁed, and 7.5-10 points as very satisﬁed. This classiﬁcation could
be criticized as patients rating 2.5 points on the VAS could theo-
retically end in either the dissatisﬁed or somewhat satisﬁed group,
and similarly, patients rating 5 points on the VAS could end in either
the somewhat satisﬁed or moderately satisﬁed group. Moreover, the
authors did not report the results of satisfaction level, including the
proportion of patients in various groups of satisfaction level. It would
also have facilitated the data interpretation if the results had been
published in the form of mean, SD, and range for various satisfac-
tion level groups.
de Boer et al13 used patient satisfaction as one of the external
anchors and calculated the MCID by estimating the mean change
in value of patients classiﬁed to be somewhat satisﬁed. A second
external anchor used in that study was the patient’s global per-
ceived effect of intervention on a 5-point Likert scale (much
improved, slightly improved, no change, slightly worsened, much
worsened). For ROC analysis, the much improved response was cat-
egorized as the improved group; those who experienced slight
improvement, no change, and slight worsening were categorized
as the “no change” group. One case of 25 patients who selected the
much worsened option was excluded from the analysis. It is rec-
ommended that for ROC analysis, all groups should be included and
no group should be excluded from the analysis.36 The study by de
Boer et al13 relied solely on the anchor-based method for MCID cal-
culation, whereas SDC and SEM values were not calculated. It is
recommended that authors should use both anchor-based and
distribution-based methods to estimate MCID.36 Moreover, assess-
ment of MCID was not at a uniform interval after the intervention;
although the mean follow-up period was 7 months, the assess-
ment was done at varying time intervals ranging from 2 months
postoperatively to 15 months after the index procedure.
Dawson et al12 calculated the MCID of the Oxford Elbow Score
(OES) in 74 patients who underwent different elbow operations. It
is unclear how many of these patients had TEA. Although SDC of
the OES pain subscale was smaller than MCID, the SDC of the OES
function and social-psychological subscales was higher than the
MCID values of corresponding subscales, and hence the results of
the OES must be interpreted with caution. The authors had calcu-
lated SDC using 90% conﬁdence upper limit of SEM. As the main
intended beneﬁts of TEA in elbow conditions are both pain relief
and improved function, it is crucial that both pain and functional
subscales show lower values of SDC compared with MCID. Postop-
erative assessment was done at a similar interval of 6 months after
the intervention, and the authors used both anchor-based and
distribution-based methods to estimate the MCID. Test-retest re-
liability was estimated in a sample of 52 subjects with a delay of
48 hours between the readings.11 In this study, test-retest reliabil-
ity was estimated in a smaller sample of 10 subjects with longer
time duration of 12 months between the readings. This could be a
possible explanation for the lower value of the reliability coeﬃ-
cient observed in our study. Higher value of the reliability coeﬃcient
is likely to lead to lowering of the value of SDC as it depends on
the value of the reliability coeﬃcient. It is also possible that a larger
sample size would show lower variability in the LES values.
In the study by Dawson et al,12 the authors did not calculate the
value of the reliability coeﬃcient for the Disabilities of the Arm,
Shoulder, and Hand and chose to impute the reliability coeﬃcient
from an earlier study by Beaton et al.4 This approach of using pre-
viously published values of the reliability coeﬃcient to estimate
MCID was also used by Angst et al.2 The original validation study
on the LES showed that the value of the reliability coeﬃcient was
0.93.30 If we had used this value of reliability coeﬃcient, the value
of SDC would be 1.1. However, we chose to calculate the reliability
coeﬃcient in this study as the patient population and interven-
tion administered are different from those in the initial validation
study.
A recent review29 on various outcome instruments for TEA com-
paring Mayo Elbow Performance Score (MEPS), Hospital for Special
Surgery scoring system, Hospital for Special Surgery Total Elbow
scoring system, Elbow Functional Assessment, American Shoulder
and Elbow Surgeons elbow assessment form, and LES found MEPS
the most commonly reported elbow score. The MCID of MEPS and
American Shoulder and Elbow Surgeons elbow assessment score has
not been reported so far. The authors concluded that comparison
of psychometric properties of the elbow scores failed to show any
major difference between the outcome instruments.
We agree with the view of Riedel and Beaton29 that a single total
value of outcome instrument should be presented instead of several
values for various subdomains like pain, function, and psychoso-
cial components. Another review35 observed that measurement error
of the LES has not been reported. This study addresses the issue of
measurement error by describing SEM and SDC.
One of the strengths of this study is the demonstration of sat-
isfactory interpretability of the psychometric property of the LES.
Interpretability is deﬁned as the ability to assign and to infer qual-
itative information from quantitative data.21 There is no consensus
regarding the ideal way to check interpretability of an outcome
measure. Terwee et al33 gave a positive rating if the outcome score
was presented as mean and SD in at least 4 subgroups of partici-
pants and if values of MCID or minimal important change were
presented. This studyhasdescribedMCIDvalues for the LES. Eechaute
et al15 considered that interpretability of an outcomemeasure could
be inferred if any 2 of the following 4 criteria were achieved: scores
presented as mean and SD, comparison of data in various sub-
groups, evaluation of correlation between change in score and
patient’s global assessmentof change, andcorrelationbetweenchange
in score and other commonly used outcome measures. Another
study39 described the LES in 4 subgroups of patients based onpatient
satisfaction after the total elbow replacement. The mean change in
LES and the SD of the change score were estimated for unsatisﬁed,
somewhat satisﬁed, satisﬁed, and very satisﬁed patients. Themean
change in LES increased as patient satisfaction improved.
This study has its limitations. The value of the reliability coef-
ﬁcient was 0.85, which was lower than the reliability coeﬃcient
(0.93) reported for the initial validation study.30,31 Possible expla-
nations for this could be the difference in the outcome evaluation
time. It is likely that evaluation at 1 year after the index proce-
dure was long. Test-retest validity in the original validation study
was performed between 1 and 3 days after the initial evaluation.
It is recommended that the value of the test-retest reliability co-
eﬃcient should be >0.70 to be considered satisfactory.15 Our value
is still acceptable as it is higher than this recommended value.
It is unknown whether the MCID is disease speciﬁc or interven-
tion speciﬁc. It is possible that theMCID of the LESmight be different
in rheumatoid arthritis, which usually affects multiple joints, and
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in post-traumatic arthritis, wherein the elbow arthroplasty would
eradicate the condition of the single joint. Future studies could in-
vestigate whether MCID is different for type of surgical interventions
(primary and revision TEA) or type of pathologic process (inﬂam-
matory and noninﬂammatory elbow arthritis).
Conclusion
The MCID value for the LES is expected to be between 0.7 and
1.8. As the SDC value was estimated as 1.5, we recommend using
the MCID value of 1.6, which is greater than the value of SDC and
hence more likely to represent a true change in the clinical condi-
tion of the patient.
Disclaimer
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